UnitedHealth Group Inc
UNH· NYSE
UNHUnitedHealth Group Inc
Quarterly figures for UnitedHealth Group Inc, with source filings when available.
73 quarters. Jun 30, 2008 to Jun 30, 2026. USD.
UnitedHealth Group Inc has filed its 10-Q within 28 to 42 days of period end across its last 8 quarters. The 10-K runs 12 to 61 days.
UnitedHealth Group Inc · CIK 731766 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 16, 2026 · pre-market | Aug 10, 2026 | 41 d | 10-Q | $112.03B | +0.4% | $6.04 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 21, 2026 · pre-market |
| May 5, 2026 |
| 35 d |
| 10-Q |
| $111.72B |
| +2.0% |
| $6.90 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Jan 27, 2026 · pre-market | Mar 2, 2026 | 61 d | 10-K | $113.22B | +12.3% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 28, 2025 · pre-market | Oct 28, 2025 | 28 d | 10-Q | $113.16B | +12.2% | $2.59 | |
| Q2 2025 | Jun 30, 2025 | Jul 29, 2025 · pre-market | Aug 11, 2025 | 42 d | 10-Q | $111.62B | +12.9% | $3.74 | |
| Q1 2025 | Mar 31, 2025 | Apr 17, 2025 · pre-market | May 7, 2025 | 37 d | 10-Q | $109.58B | +9.8% | $6.85 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Jan 16, 2025 · pre-market | Feb 27, 2025 | 58 d | 10-K | $100.81B | +6.8% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 15, 2024 · pre-market | Nov 4, 2024 | 35 d | 10-Q | $100.82B | +9.2% | $6.51 | |
| Q2 2024 | Jun 30, 2024 | Jul 16, 2024 · pre-market | Aug 9, 2024 | 40 d | 10-Q | $98.86B | +6.4% | $4.54 | |
| Q1 2024 | Mar 31, 2024 | Apr 16, 2024 · pre-market | May 9, 2024 | 39 d | 10-Q | $99.80B | +8.6% | -$1.53 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Jan 12, 2024 · pre-market | Feb 28, 2024 | 59 d | 10-K | $94.43B | +14.1% | — | |
| Q3 2023 | Sep 30, 2023 | Oct 13, 2023 · pre-market | Nov 6, 2023 | 37 d | 10-Q | $92.36B | +14.2% | $6.24 | |
| Q2 2023 | Jun 30, 2023 | Jul 14, 2023 · pre-market | Aug 2, 2023 | 33 d | 10-Q | $92.90B | +15.6% | $5.82 | |
| Q1 2023 | Mar 31, 2023 | Apr 14, 2023 · pre-market | May 3, 2023 | 33 d | 10-Q | $91.93B | +14.7% | $5.95 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Jan 13, 2023 · pre-market | Feb 24, 2023 | 55 d | 10-K | $82.79B | +12.3% | — | |
| Q3 2022 | Sep 30, 2022 | Oct 14, 2022 · pre-market | Nov 2, 2022 | 33 d | 10-Q | $80.89B | +11.8% | $5.55 | |
| Q2 2022 | Jun 30, 2022 | Jul 15, 2022 · pre-market | Aug 3, 2022 | 34 d | 10-Q | $80.33B | +12.6% | $5.34 | |
| Q1 2022 | Mar 31, 2022 | Apr 14, 2022 · pre-market | May 4, 2022 | 34 d | 10-Q | $80.15B | +14.2% | $5.27 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Jan 19, 2022 · pre-market | Feb 15, 2022 | 46 d | 10-K | $73.74B | +12.6% | — | |
| Q3 2021 | Sep 30, 2021 | Oct 14, 2021 · pre-market | Nov 3, 2021 | 34 d | 10-Q | $72.34B | +11.1% | $4.28 | |
| Q2 2021 | Jun 30, 2021 | Jul 15, 2021 · pre-market | Aug 3, 2021 | 34 d | 10-Q | $71.32B | +14.8% | $4.46 | |
| Q1 2021 | Mar 31, 2021 | Apr 15, 2021 · pre-market | May 5, 2021 | 35 d | 10-Q | $70.20B | +9.0% | $5.08 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Jan 20, 2021 · pre-market | Mar 1, 2021 | 60 d | 10-K | $65.47B | +7.5% | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $65.12B | +7.9% | $3.30 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $62.14B | +2.5% | $6.91 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $64.42B | +6.8% | $3.52 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | $60.90B | +4.3% | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | $60.35B | +6.7% | $3.67 | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | $60.60B | +8.0% | $3.42 | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | $60.31B | +9.3% | $3.56 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | — | — | — | $58.42B | +12.2% | — | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | $56.56B | +12.4% | $3.24 | |
| Q2 2018 | Jun 30, 2018 | — | — | — | — | $56.09B | +12.1% | $2.98 | |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | $55.19B | +13.3% | $2.87 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | — | — | — | $52.06B | +9.5% | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | $50.32B | +8.7% | $2.51 | |
| Q2 2017 | Jun 30, 2017 | — | — | — | — | $50.05B | +7.7% | $2.32 | |
| Q1 2017 | Mar 31, 2017 | — | — | — | — | $48.72B | +9.4% | $2.23 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | — | — | — | $47.54B | +9.0% | — | |
| Q3 2016 | Sep 30, 2016 | — | — | — | — | $46.29B | +11.6% | $2.03 | |
| Q2 2016 | Jun 30, 2016 | — | — | — | — | $46.49B | +28.2% | $1.81 | |
| Q1 2016 | Mar 31, 2016 | — | — | — | — | $44.53B | +24.5% | $1.67 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | — | — | — | $43.60B | +30.4% | — | |
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $41.49B | +26.6% | $1.65 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $36.26B | +11.3% | $1.64 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $35.76B | +12.8% | $1.46 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | — | — | — | $33.43B | +7.4% | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $32.76B | +7.0% | $1.63 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $32.57B | +7.1% | $1.42 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $31.71B | +4.5% | $1.10 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | — | — | — | $31.12B | +8.2% | $1.41 | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $30.62B | +12.2% | $1.53 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $30.41B | +11.5% | $1.40 | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $30.34B | +11.2% | $1.16 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | — | — | — | $28.77B | +11.0% | $1.20 | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $27.30B | +8.0% | $1.50 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $27.27B | +8.0% | $1.27 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $27.28B | +7.3% | $1.31 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | — | — | — | $25.92B | +7.8% | $1.17 | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $25.28B | +6.8% | $1.17 | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $25.23B | +8.5% | $1.16 | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $25.43B | +9.7% | $1.22 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010 | Dec 31, 2010 | — | — | — | — | $24.03B | +10.3% | $0.94 | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $23.67B | +9.1% | $1.14 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $23.26B | +7.4% | $0.99 | |
| Q1 2010 | Mar 31, 2010 | — | — | — | — | $23.19B | +5.4% | $1.03 | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009 | Dec 31, 2009 | — | — | — | — | $21.78B | — | $0.81 | |
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $21.70B | +7.6% | $0.89 | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $21.66B | +6.8% | $0.73 | |
| Q1 2009 | Mar 31, 2009 | — | — | — | — | $22.00B | — | $0.81 | |
| FY 2008 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2008derived | Dec 31, 2008 | — | — | — | — | — | — | — | |
| Q3 2008 | Sep 30, 2008 | — | — | — | — | $20.16B | — | $0.75 | |
| Q2 2008 | Jun 30, 2008 | — | — | — | — | $20.27B | — | $0.27 | |
